ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 682,34
-0,54%
Dow Jones
40 211,72
0,53%
DAX
18 590,89
-0,95%
Brent Oil
84,075
-0,31%
Bitcoin
64 635,24
-0,33%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Constellation Pharmaceuticals Inc (CNST)

  7. Constellation Pharmaceuticals Inc (CNST) Actualités

CNST

Constellation Pharmaceut... (CNST)

Constellation Pharmaceuticals Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:CNST
DateHeureSourceTitreSymboleSociété
29/11/201815h22GlobeNewswire Inc.Constellation Pharmaceuticals Appoints Patrick Trojer, Ph.D., as Chief Scientific OfficerNASDAQ:CNSTConstellation Pharmaceuticals Inc
15/11/201813h00GlobeNewswire Inc.Constellation Pharmaceuticals Highlights EZH2 Inhibition Program in Prostate Cancer at Biomedical ConferenceNASDAQ:CNSTConstellation Pharmaceuticals Inc
09/11/201812h16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CNSTConstellation Pharmaceuticals Inc
08/11/201823h31Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CNSTConstellation Pharmaceuticals Inc
08/11/201822h30GlobeNewswire Inc.Constellation Pharmaceuticals Announces Third-Quarter and Nine-Month 2018 Financial ResultsNASDAQ:CNSTConstellation Pharmaceuticals Inc
02/11/201818h08GlobeNewswire Inc.Constellation Pharmaceuticals to Present at Upcoming Investor ConferencesNASDAQ:CNSTConstellation Pharmaceuticals Inc
01/11/201812h00GlobeNewswire Inc.Constellation Pharmaceuticals Receives FDA Fast Track Designation for CPI-0610 in Treatment of MyelofibrosisNASDAQ:CNSTConstellation Pharmaceuticals Inc
31/10/201817h01Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:CNSTConstellation Pharmaceuticals Inc
10/10/201822h30GlobeNewswire Inc.Constellation Pharmaceuticals Enhances and Expands Phase 2 MANIFEST Study of CPI-0610 in MyelofibrosisNASDAQ:CNSTConstellation Pharmaceuticals Inc
12/09/201815h00GlobeNewswire Inc.Constellation Pharmaceuticals Congratulates Dr. David Allis and Dr. Michael Grunstein, Winners of the 2018 Lasker AwardNASDAQ:CNSTConstellation Pharmaceuticals Inc
05/09/201823h45Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNSTConstellation Pharmaceuticals Inc
05/09/201823h42Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CNSTConstellation Pharmaceuticals Inc
04/09/201812h30GlobeNewswire Inc.Constellation Pharmaceuticals Announces Appointments to Board of DirectorsNASDAQ:CNSTConstellation Pharmaceuticals Inc
14/08/201822h15GlobeNewswire Inc.Constellation Pharmaceuticals Announces Second-Quarter and Six-Month 2018 Financial ResultsNASDAQ:CNSTConstellation Pharmaceuticals Inc
23/07/201822h54Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:CNSTConstellation Pharmaceuticals Inc
18/01/201121h03Edgar (US Regulatory)Current report filing (8-K)NASDAQ:CNSTConstellation Pharmaceuticals Inc
14/01/201123h00Business WireConstar International Inc. Receives Delisting Notice from NASDAQ Stock MarketNASDAQ:CNSTConstellation Pharmaceuticals Inc
11/01/201118h51Business WireConstar International Inc. Receives Support of Ad Hoc Committee of Senior Secured Noteholders for a Plan to Reduce Debt & Int...NASDAQ:CNSTConstellation Pharmaceuticals Inc
11/01/201118h46Dow Jones NewsConstar Files For Chapter 11 Bankruptcy ProtectionNASDAQ:CNSTConstellation Pharmaceuticals Inc
20/12/201018h01Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CNSTConstellation Pharmaceuticals Inc
15/11/201022h56Edgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:CNSTConstellation Pharmaceuticals Inc
19/10/201012h00Business WireConstar International Inc. Announces Senior AppointmentsNASDAQ:CNSTConstellation Pharmaceuticals Inc
08/10/201015h01Business WireConstar International Inc. Announces Plans to Streamline OperationsNASDAQ:CNSTConstellation Pharmaceuticals Inc
29/09/201022h04Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:CNSTConstellation Pharmaceuticals Inc
24/09/201023h00Edgar (US Regulatory)Proxy Statement (definitive) (DEF 14A)NASDAQ:CNSTConstellation Pharmaceuticals Inc
14/09/201022h30Business WireConstar International Inc. Announces the Appointment of Grant H. Beard as CEONASDAQ:CNSTConstellation Pharmaceuticals Inc
28/04/201014h00Business WireConstar International Inc. Announces Resignation of Michael Hoffman; Ruth Mack to Serve as Interim President and CEONASDAQ:CNSTConstellation Pharmaceuticals Inc
07/04/201013h00Business WireConstar International Inc. to be Listed on NASDAQ Capital MarketNASDAQ:CNSTConstellation Pharmaceuticals Inc
09/01/200900h38Business WireCourt Enters Order Restricting Trading in Equity of Constar International Inc. and AffiliatesNASDAQ:CNSTConstellation Pharmaceuticals Inc
06/01/200903h07Business WireConstar International Inc. Receives Court Approval on “First Day” Motions in Its Reorganization FilingNASDAQ:CNSTConstellation Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:CNST

Dernières Valeurs Consultées

BIT
P253G7
NLBNPIT253G7 20250321 1100
BIT
P24955
NLBNPIT24955 20351221 35...
BIT
P250E8
NLBNPIT250E8 20240917 75
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés